Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Series A

Moa Technology debuts with $7.6m series A
University of Oxford's Moa Technology has received series A support to progress its vision of marketing potent herbicides discovered via its high-throughput, in-vivo screening platform.
Boatsetter sets sail with $27.8m series A
Stanford Daper Fund-backed Boatsetter has increased its series A to at least $27.8m with $10m from investors including WestCap Group and Valor Equity Partners.
Renovacor correlates $11m
Gene therapy developer Renovacor, a Temple University spinout, has secured series A funding from investors including Novartis Venture Fund.
Carisma dazzles with extended series A
The spinout has revealed it added approximately $6m to a series A round backed by University of Pennsylvania and IP Group last year, bringing its total size to about $59m.
BlueDot joins up $6.9m
BlueDot, a disease containment technology spinout set up by St Michael’s Hospital and Mars Innovation, has secured series A capital.
Daily deal net August 8, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Alizé Pharma 3 leads corporates to series A
Novo, Partners Healthcare and Sham all contributed to a $74.6m round for Alizé Pharma 3, which is exploiting research from three US institutions.
Truework detects $12m
Stanford University has backed a $12m series A for identity management technology developer Truework, which has been expanding its business in the employment and loan referencing space.

Other News

Synspective secures series A funding
UTokyo IPC, Keio Innovation Initiative and Innovations and Future Creation have contributed to a $79.7m series A that increased the Tokyo spinout's total funding to about $100m.
TScan takes in $48m
Harvard Medical School spinout TScan has come out of stealth with $48m in funding provided by investors including GV and two Novartis units.
Mingdu mingles for $14.5m
Cash Capital joined a unit of Red Star Macalline to back Mingdu Intelligent, which provides drug manufacturing services mainly related to data management and quality control.
X-Vax packs $56m into series A
Johnson & Johnson, Alexandria Venture Investments and Serum Institute of India contributed to a series A for Albert Einstein College of Medicine spinout X-Vax.
RoadBotics paves over $7.5m series A
CMU-founded road surface analytics technology creator RoadBotics has now raised at least $11.4m, having signed up Radical Ventures and Hyperplane VC to its series A.
Kronos cracks $105m series A
GV contributed to a round for MIT-founded small molecule cancer drug spinout Kronos Bio, adding to $18m raised by the latter 14 months ago.

Editor's Picks

Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Big deal: NMD flexes series A muscles
Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.
Immunocore smashes European biotech records
Immunotherapy firm Immunocore, which started life at Oxford University, raises the largest biotech round in European history.
Sphere Fluidics circles $2.5m
test reg

Login